Current Status and Research Progress of Immunotherapy for Colorectal Cancer
10.3971/j.issn.1000-8578.2024.24.0008
- VernacularTitle:结直肠癌免疫治疗的现状及研究进展
- Author:
Xiangchen ZHANG
1
;
Xinjun LIANG
1
;
Shaozhong WEI
1
Author Information
1. Department of Gastroenteric Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
- Publication Type:REVIEW
- Keywords:
Colorectal cancer;
Immunotherapy;
Cancer vaccines;
Adoptive cell therapy;
Immune checkpoint inhibitors
- From:
Cancer Research on Prevention and Treatment
2024;51(11):962-968
- CountryChina
- Language:Chinese
-
Abstract:
Colorectal cancer (CRC) seriously threatens people's health and safety, with high incidence and mortality rates. Surgery combined with radiotherapy and chemotherapy is the main treatment method for CRC at present, but the results are unsatisfactory. The emergence of tumor immunotherapy has brought hope to patients with CRC. Immunotherapy based on immune checkpoint inhibitors provides benefits to some patients. In addition, emerging tumor vaccines and adoptive cell therapy have achieved significant results. This paper reviews the current status and progress of immunotherapy for CRC.
